,

ARA-290 (15mg)

$95.00

ARA-290 is a non-erythropoietic peptide derived from erythropoietin, designed to retain the tissue-protective and anti-inflammatory properties of erythropoietin without stimulating erythropoiesis. It has shown promise in various therapeutic applications due to its ability to modulate immune responses and protect tissues.

Availability: 785 in stock

ARA-290 Product Description

ARA-290 is a non-erythropoietic peptide derived from erythropoietin, designed to retain the tissue-protective and anti-inflammatory properties of erythropoietin without its hematopoietic effects. This makes ARA-290 a promising candidate for research in various medical conditions where inflammation and tissue damage are prevalent.

One of the key areas of interest is its potential in treating neuropathic pain and metabolic disorders. In patients with type 2 diabetes, ARA-290 has shown promise in improving metabolic control and alleviating neuropathic symptoms, suggesting a role in both metabolic and nerve health.

Peptide Information

Property Value
Peptide Sequence pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Molecular Formula C51H84N16O21
Molecular Weight 1257.3 g/mol
CAS Number 1208243-50-8
PubChem CID 91810664
Synonyms Cibinetide, 1208243-50-8, ARA290, PHBSP, ARA 290

ARA-290 Structure

ARA-290 peptide structure

Source PubChem

Weight 0.250 lbs
Dimensions 0.625 × 0.625 × 1.5 in
Dutify Classification ID

6064

Scroll to Top